REMEDi4ALL - Standard Operating Procedure - A high-content screening assay to evaluate small molecule-induced phospholipidosis in cells
This guideline describes the protocol of using high-content imaging to evaluate small molecule-induced phospholipidosis in cells, which might be an undesirable mechanism of action (MOA) of nuisance compounds in cell-based assays. The protocol has been applied for U2OS and A549 cells but can be adapted to other cell lines.
Institutions
- Karolinska Institutet (SE)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-02-14
- DOI
- https://doi.org/10.5281/zenodo.14872165
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00